Uterine leiomyosarcoma metastasizing to the heart.
Uterine leiomyosarcoma is an uncommon and aggressive gynecologic malignancy with an overall poor prognosis. Lungs, bones and brain are common sites of metastases of uterine leiomyosarcoma. Metastases of uterine leiomyosarcoma to the heart are extremely rare, and only a few case reports have been published so far. Herein we present the case of 57 years old female, who had undergone total abdominal hysterectomy with salpingo-oophorectomy 10 years back for uterine leiomyosarcoma, she presented with dyspnea, dizziness, fever, and tachycardia, subsequently was found to have interventricular septum cardiac as well extensive system metastasis and recurrent pelvic mass. Patient's symptoms responded to palliative radiotherapy followed by chemotherapy.
Department of Radiation Oncology, Comprehensive Cancer Centre, King Fahad Medical City, Riyadh-59046, Saudi Arabia.
Mutahir Ali
MA
Tunio
Department of Radiation Oncology, Comprehensive Cancer Centre, King Fahad Medical City, Riyadh-59046, Saudi Arabia.
Mushabbab
M
Al-Asiri
Department of Radiation Oncology, Comprehensive Cancer Centre, King Fahad Medical City, Riyadh-59046, Saudi Arabia.
Muhammad Mohsin
MM
Fareed
D000970:Antineoplastic Agents / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D005260:Female; D006338:Heart Neoplasms / Q000473:pathology* / Q000556:secondary / Q000628:therapy; D006801:Humans; D007890:Leiomyosarcoma / Q000473:pathology* / Q000556:secondary* / Q000628:therapy; D008875:Middle Aged; D011878:Radiotherapy; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D014594:Uterine Neoplasms / Q000473:pathology* / Q000556:secondary* / Q000628:therapy
D000970:Antineoplastic Agents